
Glenn Graham
85:46 - 86:14
"No, in fact, Senator, I can't, particularly given the accomplishments of VA. I think this comes at a very bad time. It's already been alluded that other federal sources of funding, including NIH, are facing great uncertainties now. VA research being a constant, you know, reliable source of support for research helping veterans certainly would be, would be very welcome."
“No, in fact, Senator, I can't, particularly given the accomplishments of VA. I think this comes at a very bad time. It's already been alluded that other federal sources of funding, including NIH, are facing great uncertainties now. VA research being a constant, you know, reliable source of support for research helping veterans certainly would be, would be very welcome.”
Can you think of any justification for that kind of cut? No, in fact, Senator, I can't, particularly given the accomplishments of VA. I think this comes at a very bad time. It's already been alluded that other federal sources of funding, including NIH, are facing great uncertainties now. VA research being a constant, you know, Reliable source of support for research helping veterans certainly would be, would be very welcome.
The Senate Veterans' Affairs Committee held a broad hearing Wednesday on the future of VA research, covering hiring delays, budget cuts, NIH funding instability, and clinical trial disruptions. Senators also questioned whether a $5 million FY2024 appropriation for the VA prostate cancer precision oncology program was spent as Congress intended.
